Literature DB >> 22188796

Optimizing of preoperative computed tomography for diagnosis in patients with peritoneal carcinomatosis.

Carolin D Duhr1, Werner Kenn, Ralph Kickuth, Alexander G Kerscher, Christoph-Thomas Germer, Dietbert Hahn, Joerg O W Pelz.   

Abstract

BACKGROUND AND
OBJECTIVE: This study evaluates whether Computer Tomography is an effective procedure for preoperative staging of patients with Peritoneal Carcinomatosis.
METHOD: A sample of 37 patients was analyzed with contrast enhanced abdominal Computer Tomography, followed by surgical staging. All Computer Tomography scans were evaluated 3 times by 2 radiologists with one radiologist reviewing 2 times. The efficacy of Computer Tomography was evaluated using the Spearman correlation coefficient. Correlations were analyzed by abdominopelvic region to assess results of the Peritoneal Carcinomatosis Index (PCI) aggregating the 13 regions. Surgical findings were compared to radiological findings.
RESULTS: Results indicate high correlations between the surgical and radiological Peritoneal Carcinomatosis Indices. Analyses of the intra-class correlation between the first and second reading of one radiologist suggest high intra-observer reliability. Correlations by abdominopelvic region show higher values in the upper and middle regions and relatively lower values in the lower regions and the small bowel (correlation coefficients range between 0.418 and 0.726, p < 0.010; sensitivities range between 50% and 96%; and specificities range between 62% and 100%).
CONCLUSION: Computer Tomography represents an effective procedure in the preoperative staging of patients with PC. However, results by abdominopelvic region show lower correlation, therefore suggest lower efficacy. These results are supported by analyses of sensitivity and accuracy by lesion size. This suggests that Computer Tomography is an effective procedure for pre-operative staging but less for determining a tumor's accurate extent.

Entities:  

Mesh:

Year:  2011        PMID: 22188796      PMCID: PMC3280941          DOI: 10.1186/1477-7819-9-171

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  38 in total

Review 1.  Peritoneal carcinomatosis.

Authors:  V Raptopoulos; N Gourtsoyiannis
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

2.  Staging of advanced ovarian cancer: comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group.

Authors:  C M Tempany; K H Zou; S G Silverman; D L Brown; A B Kurtz; B J McNeil
Journal:  Radiology       Date:  2000-06       Impact factor: 11.105

Review 3.  Management of peritoneal-surface malignancy: the surgeon's role.

Authors:  P H Sugarbaker
Journal:  Langenbecks Arch Surg       Date:  1999-12       Impact factor: 3.445

Review 4.  Intraperitoneal chemotherapy for colorectal cancer.

Authors:  Eelco de Bree; A J Witkamp; Frans A N Zoetmulder
Journal:  J Surg Oncol       Date:  2002-01       Impact factor: 3.454

5.  Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma.

Authors:  R A Kubik-Huch; W Dörffler; G K von Schulthess; B Marincek; O R Köchli; B Seifert; U Haller; H C Steinert
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

6.  Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study.

Authors:  B Sadeghi; C Arvieux; O Glehen; A C Beaujard; M Rivoire; J Baulieux; E Fontaumard; A Brachet; J L Caillot; J L Faure; J Porcheron; J L Peix; Y François; J Vignal; F N Gilly
Journal:  Cancer       Date:  2000-01-15       Impact factor: 6.860

7.  Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.

Authors:  P H Sugarbaker; D Chang
Journal:  Ann Surg Oncol       Date:  1999-12       Impact factor: 5.344

Review 8.  Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.

Authors:  A J Witkamp; E de Bree; R Van Goethem; F A Zoetmulder
Journal:  Cancer Treat Rev       Date:  2001-12       Impact factor: 12.111

9.  Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin.

Authors:  A J Witkamp; E de Bree; M M Kaag; H Boot; J H Beijnen; G W van Slooten; F van Coevorden; F A Zoetmulder
Journal:  Eur J Cancer       Date:  2001-05       Impact factor: 9.162

10.  Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer.

Authors:  A T Culliford; A D Brooks; S Sharma; L B Saltz; G K Schwartz; E M O'Reilly; D H Ilson; N E Kemeny; D P Kelsen; J G Guillem; W D Wong; A M Cohen; P B Paty
Journal:  Ann Surg Oncol       Date:  2001-12       Impact factor: 5.344

View more
  14 in total

Review 1.  Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis.

Authors:  Andrea Laghi; Davide Bellini; Marco Rengo; Fabio Accarpio; Damiano Caruso; Daniele Biacchi; Angelo Di Giorgio; Paolo Sammartino
Journal:  Radiol Med       Date:  2016-09-19       Impact factor: 3.469

2.  Accuracy of CT Scan in Predicting the Surgical PCI in Patients Undergoing Cytoreductive Surgery with/without HIPEC-a Prospective Single Institution Study.

Authors:  Gaurav Goswami; Praveen Kammar; Ramesh Mangal; Sakina Shaikh; Mahesh D Patel; Aditi Bhatt
Journal:  Indian J Surg Oncol       Date:  2019-03-28

Review 3.  Imaging of pre- and post-cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pediatric intraperitoneal malignancy.

Authors:  Nathan C Hull; Candace F Granberg; Patricio C Gargollo; Paul G Thacker
Journal:  Pediatr Radiol       Date:  2022-10-07

4.  Accuracy of radiologic- laparoscopic peritoneal carcinomatosis categorization in the prediction of surgical outcome.

Authors:  Shimaa Abdalla Ahmed; Hisham Abou-Taleb; Noha Ali; Dalia M Badary
Journal:  Br J Radiol       Date:  2019-05-24       Impact factor: 3.039

5.  Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients.

Authors:  Florian Seyfried; Burkhard H von Rahden; Alexander D Miras; Martin Gasser; Uwe Maeder; Volker Kunzmann; Christoph-Thomas Germer; Jörg Pelz; Alexander G Kerscher
Journal:  BMC Cancer       Date:  2015-02-19       Impact factor: 4.430

6.  Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis: a phase II study.

Authors:  Florian Struller; Philipp Horvath; Wiebke Solass; Frank-Jürgen Weinreich; Dirk Strumberg; Marios K Kokkalis; Imma Fischer; Christoph Meisner; Alfred Königsrainer; Marc A Reymond
Journal:  Ther Adv Med Oncol       Date:  2019-05-13       Impact factor: 8.168

Review 7.  Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research.

Authors:  Foteini Stefania Koumpa; Diamantis Xylas; Maciej Konopka; Dieter Galea; Kirill Veselkov; Anthony Antoniou; Akash Mehta; Reza Mirnezami
Journal:  Gastroenterol Res Pract       Date:  2019-04-01       Impact factor: 2.260

8.  Laparoscopy and Computed Tomography Imaging in Advanced Ovarian Tumors: A Roadmap for Prediction of Optimal Cytoreductive Surgery.

Authors:  Ahmed Samy El-Agwany
Journal:  Gynecol Minim Invasive Ther       Date:  2018-05-02

9.  Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters.

Authors:  Hanna Sartor; Maria Bjurberg; Mihaela Asp; Anna Kahn; Jenny Brändstedt; Päivi Kannisto; Karin Jirström
Journal:  J Ovarian Res       Date:  2020-03-07       Impact factor: 4.234

10.  Value of preoperative ultrasound in evaluating the peritoneal cancer index of pseudomyxoma peritonei.

Authors:  Lei Liang; Wenhai Wang; Nan Zhou; Jun Guo; Yiyan Lu; Hongbin Xu; Shutian Zhang
Journal:  World J Surg Oncol       Date:  2019-11-12       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.